My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 146

    1.

    PTEN deficiency: a role in mammary carcinogenesis.

    Petrocelli T, Slingerland JM.

    Breast Cancer Res. 2001;3(6):356-60. Epub 2001 Oct 1. Review.PMID: 11737885 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.

    Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB, Mak TW.

    Cancer Res. 2000 Jul 1;60(13):3605-11.PMID: 10910075 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations.

    Zhang X, Podsypanina K, Huang S, Mohsin SK, Chamness GC, Hatsell S, Cowin P, Schiff R, Li Y.

    Oncogene. 2005 Jun 16;24(26):4220-31.PMID: 15824740 [PubMed - indexed for MEDLINE]Related articles

    4.

    Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.

    Perren A, Weng LP, Boag AH, Ziebold U, Thakore K, Dahia PL, Komminoth P, Lees JA, Mulligan LM, Mutter GL, Eng C.

    Am J Pathol. 1999 Oct;155(4):1253-60.PMID: 10514407 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice.

    Li Y, Podsypanina K, Liu X, Crane A, Tan LK, Parsons R, Varmus HE.

    BMC Mol Biol. 2001;2:2. Epub 2001 Jan 23.PMID: 11178110 [PubMed]Related articlesFree article

    6.

    High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.

    Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M, Mak TW.

    Curr Biol. 1998 Oct 22;8(21):1169-78.PMID: 9799734 [PubMed - indexed for MEDLINE]Related articles

    7.

    Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.

    Freihoff D, Kempe A, Beste B, Wappenschmidt B, Kreyer E, Hayashi Y, Meindl A, Krebs D, Wiestler OD, von Deimling A, Schmutzler RK.

    Br J Cancer. 1999 Feb;79(5-6):754-8.PMID: 10070865 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland.

    Li G, Robinson GW, Lesche R, Martinez-Diaz H, Jiang Z, Rozengurt N, Wagner KU, Wu DC, Lane TF, Liu X, Hennighausen L, Wu H.

    Development. 2002 Sep;129(17):4159-70.PMID: 12163417 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.

    Kurose K, Zhou XP, Araki T, Eng C.

    Genes Chromosomes Cancer. 2000 Oct;29(2):166-72.PMID: 10959096 [PubMed - indexed for MEDLINE]Related articles

    10.

    Tumorigenesis facilitated by Pten deficiency in the skin: evidence of p53-Pten complex formation on the initiation phase.

    Komazawa N, Suzuki A, Sano S, Horie K, Matsuura N, Mak TW, Nakano T, Takeda J, Kondoh G.

    Cancer Sci. 2004 Aug;95(8):639-43. Retraction in: Tsuruo T. Cancer Sci. 2005 Jun;96(6):377. PMID: 15298725 [PubMed - indexed for MEDLINE]Related articles

    11.

    Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression.

    Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M.

    Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11563-8. Epub 2001 Sep 11.PMID: 11553783 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.

    Frisk T, Foukakis T, Dwight T, Lundberg J, Höög A, Wallin G, Eng C, Zedenius J, Larsson C.

    Genes Chromosomes Cancer. 2002 Sep;35(1):74-80.PMID: 12203792 [PubMed - indexed for MEDLINE]Related articles

    13.

    PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.

    Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, Yu JS, Malmström PO, Mansukhani M, Enoksson J, Hibshoosh H, Borg A, Parsons R.

    Cancer Res. 2005 Apr 1;65(7):2554-9.PMID: 15805248 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Dysregulated PTEN-PKB and negative receptor status in human breast cancer.

    Shi W, Zhang X, Pintilie M, Ma N, Miller N, Banerjee D, Tsao MS, Mak T, Fyles A, Liu FF.

    Int J Cancer. 2003 Mar 20;104(2):195-203.PMID: 12569575 [PubMed - indexed for MEDLINE]Related articles

    15.

    PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.

    Zhou XP, Loukola A, Salovaara R, Nystrom-Lahti M, Peltomäki P, de la Chapelle A, Aaltonen LA, Eng C.

    Am J Pathol. 2002 Aug;161(2):439-47.PMID: 12163369 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Knockout mouse models and mammary tumorigenesis.

    Deng CX, Brodie SG.

    Semin Cancer Biol. 2001 Oct;11(5):387-94. Review.PMID: 11562181 [PubMed - indexed for MEDLINE]Related articles

    17.

    Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice.

    You MJ, Castrillon DH, Bastian BC, O'Hagan RC, Bosenberg MW, Parsons R, Chin L, DePinho RA.

    Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1455-60. Epub 2002 Jan 29.PMID: 11818530 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.

    Van Gele M, Leonard JH, Van Roy N, Cook AL, De Paepe A, Speleman F.

    Int J Cancer. 2001 May 1;92(3):409-13.PMID: 11291079 [PubMed - indexed for MEDLINE]Related articles

    19.

    Physiological functions of Pten in mouse tissues.

    Kishimoto H, Hamada K, Saunders M, Backman S, Sasaki T, Nakano T, Mak TW, Suzuki A.

    Cell Struct Funct. 2003 Feb;28(1):11-21. Review.PMID: 12655146 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.

    Feilotter HE, Coulon V, McVeigh JL, Boag AH, Dorion-Bonnet F, Duboué B, Latham WC, Eng C, Mulligan LM, Longy M.

    Br J Cancer. 1999 Feb;79(5-6):718-23.PMID: 10070859 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk